Veracyte reported $26.01M in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Agenus AGEN:US USD 308K 1.72M
Agilent A:US USD 837M 58M
Anika Therapeutics ANIK:US USD 17.48M 2.69M
Biocept BIOC:US USD 5.78M 2.25M
Bruker BRKR:US USD 303.8M 14.9M
Exact Sciences EXAS:US USD 147.94M 3.34M
Heron Therapeutics HRTX:US USD 14.72M 1.46M
Illumina ILMN:US USD 398M 3M
Intrexon XON:US USD 1.58M 234K
Karyopharm Therapeutics KPTI:US USD 980K 41K
Laboratory Of America LH:US USD 2.55B 27.8M
Ligand Pharmaceuticals LGND:US USD 14.15M 1.79M
Myriad Genetics MYGN:US USD 50.4M 700K
Rigel Pharmaceuticals RIGL:US USD 250K 786K
Roche Holding ROG:VX 9.56B 717M
Siemens SIE:GR EUR 12.9B 1.26B
Sonic Healthcare SHL:AU AUD 793.49M 17.47M
Thermo Fisher Scientific TMO:US USD 6.72B 340M
Veracyte VCYT:US USD 26.01M 978K
Waters WAT:US USD 307.1M 105K